PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24124592-7	2013	While leucine supplementation was able to minimize increased expression of both Mafbx/Atrogin and MuRF1 in immobilized rats, leucine was only able to minimize Mafbx/Atrogin in dexamethasone treated rats.	Leucine	6-13	tripartite motif containing 63	Rattus norvegicus	98-103	
20082419-5	2010	Interestingly, leucine supplementation severely minimized the early transient increase in E3 ligase [muscle ring finger 1 (MuRF1) and muscle atrophy F-box (MAFbx)/atrogin-1] gene expression observed during immobilization.	Leucine	15-22	tripartite motif containing 63	Rattus norvegicus	123-128	
28009536-11	2017	The mRNA expression of NF-kappaB, muscle atrophy F-box (MAFbx), and muscle ring finger 1 (MuRF1) was upregulated by the LPS challenge in gastrocnemius muscles, but was downregulated by Leu supplementation.	Leucine	185-188	tripartite motif containing 63	Rattus norvegicus	90-95	
28436000-1	2017	Our aim is to gain insight into the mechanisms underlying the anti-atrophic effects of leucine, namely, the way that this amino acid can restrain the up-regulation of MuRF1 and Mafbx/Atrogin-1 in muscle atrophy.	Leucine	87-94	tripartite motif containing 63	Rattus norvegicus	167-172	
28436000-9	2017	Finally, the pharmacological inhibition of VPS34 in primary myotubes prevented the protective effects of leucine upon MuRF1 and Mafbx/Atrogin-1 gene expression.	Leucine	105-112	tripartite motif containing 63	Rattus norvegicus	118-123	
31020406-5	2019	Utilizing immunoblotting, we discovered that leucine supplementation is able to inhibit the rise in autophagy-related protein expression (including LC3, Atrogin-1, MuRF1, Bnip3 and FoxO3) driven by tendon transection.	Leucine	45-52	tripartite motif containing 63	Rattus norvegicus	164-169